Superstock Investor
Member Login   RSS ->
James DiGeorgia, Mr. Macro
- Chief Editor -
Mr. Macro
Geoff Garbacz, Mr. Micro
- Chief Strategist -
Mr. Micro
Dan Hassey, Mr. Retirement
- Senior Stock Analyst -
Mr. Retirement
Superstock Investor

[Printable Version of This Page]

Today's Superstock Investor Stock Scorecard:

by Superstock Investor

April 27, 2018


Celgene (CELG) has struggled over the past year. The stock peak last fall at $147 and is now at $92.08. As such, we thought it made sense to see what the price target and upper bound are for Celgene.

Company Information

Sector: Pharmaceuticals
Industry: Biotechnology
Market Cap:  $91,520 (Millions)


  Price %Gain  
Current Price $119.98    
Price Target $95.04 -20.8%  
Upper Bound $131.48 9.6%  
Lower Bound $77.24 -35.6%  

Fundamental Variables

P/E Ratio 27.8    
Sales Growth 27.0%    

Valuation Variables

  Past Current Future
Profitability (CFROI) 20.6% 19.4% 16.0%
Growth (in Assets) 29.1% 15.8% 15.7%
Color Legend
Excellent Top 10%
Good 11- 30%
Average 31- 70%
Fair 71- 90%
Poor Bottom 10%

Stock data last updated 01/10/2017.

Data provided by QPI, Inc. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. QPI, Inc. is not liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this page, you agree not to redistribute the information found herein.

Stock Scorecard Archives